Eli Lilly LLY2.37%increase; green up pointing triangle Chief Executive Dave Ricks was on stage with Nvidia NVDA 0.61%increase; green up pointing triangle founder Jensen Huang earlier this year in San ...
It’s hard to deny the momentum of prediction markets. Platforms like Polymarket and Kalshi gained widespread attention in 2024 for letting people wager money on the U.S. presidential election, but ...
Derivatives can provide a gut check on how traders feel about future events, but prediction markets can be much more direct. It's hard to deny the momentum of prediction markets. Platforms like ...
Connecticut lawmakers are currently considering new education policies that would make schools “phone-free zones” and create statewide guidelines for artificial intelligence in classrooms. While these ...
Current Climate brings you the latest news about the business of sustainability every Monday. Sign up to get it in your inbox. An exploratory well at Zanskar's Big Blind site in Nevada. Interest in ...
2 Grey Henson, Sarah Stiles and More Join ICEBOY! at Goodman Theatre The play reminds me in some ways of Albee’s WHO’S AFRAID OF Virginia Woolf? — though the stakes are less serious, more comedic.
Hundreds of San Diego residents and community leaders criticized Mayor Todd Gloria’s new proposed budget Monday for cutting money for arts, library hours, recreation centers, youth services and other ...
AI developer Anthropic says its newest Claude artificial intelligence model is so good at finding cybersecurity vulnerabilities that it's not releasable to the public. The company is instead providing ...
To find the mallet at Howling Hills, go to the table directly beside the huge gate that a number of NPCs are working on, and you can find the mallet there, beside some other tools. If you watch the ...
Court documents show members of a Department of Energy working group used personal email addresses. Senate Democrats are investigating Department of Energy appointees’ use of personal email addresses ...
Finerenone significantly improves eGFR slope in patients with nondiabetic chronic kidney disease, suggesting a slowed progression of renal decline. Topline results were announced from a phase 3 trial ...